Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FFBC
|
Thomas Murray Obrien
Director |
BUY
Open market or private purchase
|
Direct | 899 Added 2.55% |
$12,487
$13.89 p/Share
|
Jun 30
2020 |
|
FFBC
|
William G Barron
Director |
BUY
Open market or private purchase
|
Direct | 899 Added 1.11% |
$12,487
$13.89 p/Share
|
Jun 30
2020 |
|
FFBC
|
John T Neighbours
Director |
BUY
Open market or private purchase
|
Direct | 449 Added 2.93% |
$6,237
$13.89 p/Share
|
Jun 30
2020 |
|
FFBC
|
Maribeth S Rahe
Director |
BUY
Open market or private purchase
|
Direct | 899 Added 2.2% |
$12,487
$13.89 p/Share
|
Jun 30
2020 |
|
FFBC
|
Cynthia O Booth
Director |
BUY
Open market or private purchase
|
Direct | 674 Added 2.49% |
$9,362
$13.89 p/Share
|
Jun 30
2020 |
|
FFBC
|
J Wickliffe Ach
Director |
BUY
Open market or private purchase
|
Direct | 224 Added 0.76% |
$3,111
$13.89 p/Share
|
Jun 30
2020 |
|
FFBC
|
Knust Susan L Purkrabek
Director |
BUY
Open market or private purchase
|
Direct | 224 Added 0.41% |
$3,111
$13.89 p/Share
|
Jun 30
2020 |
|
FUSN
|
Johnson & Johnson
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 725,000 Added 16.49% |
$12,325,000
$17.0 p/Share
|
Jun 30
2020 |
|
AKUS
|
Novartis Bioventures LTD |
BUY
Open market or private purchase
|
Indirect | 125,000 Added 9.57% |
$2,125,000
$17.0 p/Share
|
Jun 30
2020 |
|
RMTI
|
David S. Richmond
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 4,868 Added 2.58% |
$9,493
$1.95 p/Share
|
Jun 30
2020 |
|
RMTI
|
David S. Richmond
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 19,813 Added 13.28% |
$38,239
$1.93 p/Share
|
Jun 30
2020 |
|
WHLRL
|
Joseph Stilwell
Director |
BUY
Open market or private purchase
|
Indirect | 24,000 Added 2.64% |
$42,720
$1.78 p/Share
|
Jun 30
2020 |
|
IDYA
|
Bvf Partners L P |
BUY
Open market or private purchase
|
Direct | 2,531 Added 1.05% |
$33,713
$13.32 p/Share
|
Jun 30
2020 |
|
AKUS
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect | 290,000 Added 26.85% |
$4,930,000
$17.0 p/Share
|
Jun 30
2020 |
|
FUSN
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Indirect | 898,000 Added 34.71% |
$15,266,000
$17.0 p/Share
|
Jun 30
2020 |
|
AKUS
|
Ra Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 825,000 Added 26.56% |
$14,025,000
$17.0 p/Share
|
Jun 30
2020 |
|
AKUS
|
Eco R1 Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,176,000 Added 37.31% |
$19,992,000
$17.0 p/Share
|
Jun 30
2020 |
|
ACI
|
Juliette Williams Pryor
EVP, GC & Secretary |
BUY
Open market or private purchase
|
Direct | 2,500 Added 50.0% |
$40,000
$16.0 p/Share
|
Jun 30
2020 |
|
ACI
|
Michael T Theilmann
EVP & Chief HR Officer |
BUY
Open market or private purchase
|
Direct | 2,500 Added 5.82% |
$40,000
$16.0 p/Share
|
Jun 30
2020 |
|
AGM
|
Everett M Dobrinski
Director |
BUY
Open market or private purchase
|
Direct | 30 Added 0.44% |
$1,862
$62.07 p/Share
|
Jun 30
2020 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 68,670 Reduced 0.06% |
$19,905,373
$289.87 p/Share
|
Jun 29
2020 |
|
RYTM
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect | 52,049 Reduced 0.98% |
$1,154,967
$22.19 p/Share
|
Jun 29
2020 |
|
AUB
|
Michael W Clarke |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.4% |
$45,000
$22.5 p/Share
|
Jun 29
2020 |
|
PRTS
|
David Kanen
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 199,400 Reduced 9.65% |
$1,776,654
$8.91 p/Share
|
Jun 29
2020 |
|
DNLI
|
Douglas K Bratton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 82,578 Reduced 7.39% |
$1,995,910
$24.17 p/Share
|
Jun 29
2020 |
|
VXRT
|
Armistice Capital, LLC
Director |
SELL
Open market or private sale
|
Direct | 9,385,386 Reduced 98.47% |
$77,804,850
$8.29 p/Share
|
Jun 29
2020 |
|
VXRT
|
Armistice Capital, LLC
Director |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Jun 29
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$2,734,800
$182.32 p/Share
|
Jun 29
2020 |
|
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct | 2,501 Reduced 10.33% |
$529,912
$211.88 p/Share
|
Jun 29
2020 |
|
ACN
|
Jean Marc Ollagnier
CEO EMEA |
SELL
Open market or private sale
|
Direct | 949 Reduced 0.54% |
$200,818
$211.61 p/Share
|
Jun 29
2020 |
|
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,125 Reduced 4.82% |
$238,230
$211.76 p/Share
|
Jun 29
2020 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 11,431 Reduced 0.01% |
$1,871,255
$163.7 p/Share
|
Jun 29
2020 |
|
QCOM
|
Donald J Rosenberg
General Counsel |
SELL
Open market or private sale
|
Direct | 11,038 Reduced 75.45% |
$967,812
$87.68 p/Share
|
Jun 29
2020 |
|
ORCL
|
Lawrence Joseph Ellison
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,400,000 Reduced 0.12% |
$76,565,998
$54.69 p/Share
|
Jun 29
2020 |
|
FSR
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.07% |
$53,500
$10.7 p/Share
|
Jun 29
2020 |
|
ONEM
|
Carlyle Group Management L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,545,000 Reduced 26.8% |
$224,539,202
$29.76 p/Share
|
Jun 29
2020 |
|
NVNO
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct | 68,094 Reduced 2.98% |
$26,557
$0.39 p/Share
|
Jun 29
2020 |
|
FRG
|
B. Riley Financial, Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 3.56% |
$536,000
$21.44 p/Share
|
Jun 29
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 236 Added 0.08% |
$134,522
$570.01 p/Share
|
Jun 29
2020 |
|
EVLO
|
Flagship Ventures Fund Iv General Partner LLC |
BUY
Open market or private purchase
|
Indirect | 4,666,666 Added 34.62% |
$17,499,998
$3.75 p/Share
|
Jun 29
2020 |
|
VGR
|
Paul V Carlucci |
BUY
Open market or private purchase
|
Direct | 142 Added 0.97% |
$1,473
$10.37 p/Share
|
Jun 29
2020 |
|
REGN
|
George L Sing
Director |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 0.0% |
$1,825,530
$608.51 p/Share
|
Jun 29
2020 |
|
REGN
|
Robert E Landry
EVP Finance CFO |
SELL
Open market or private sale
|
Direct | 400 Reduced 1.64% |
$245,040
$612.6 p/Share
|
Jun 29
2020 |
|
U
|
John S. Riccitiello
President and CEO |
SELL
Open market or private sale
|
Indirect | 43,583 Reduced 100.0% |
$1,285,698
$29.5 p/Share
|
Jun 27
2020 |
|
PFXNZ
|
Fortress Investment Group LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 8,540 Reduced 0.13% |
$6,917
$0.81 p/Share
|
Jun 26
2020 |
|
ORCL
|
Lawrence Joseph Ellison
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,400,000 Reduced 0.12% |
$75,754,001
$54.11 p/Share
|
Jun 26
2020 |
|
RYTM
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect | 86,706 Reduced 1.6% |
$2,021,117
$23.31 p/Share
|
Jun 26
2020 |
|
PRTS
|
David Kanen
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,558 Reduced 1.46% |
$127,382
$8.75 p/Share
|
Jun 26
2020 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 0.68% |
$671,707
$60.81 p/Share
|
Jun 26
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$2,784,900
$185.66 p/Share
|
Jun 26
2020 |